MIT s recent investment in Marksans Pharma underscores the small-cap s hidden gem status, fuelled by its strong presence in stable OTC markets and strategic growth initiatives, signalling promising prospects for revenue and profit expansion.
Marksans Pharma on Wednesday said that it has completed the acquisition of a manufacturing site from Tevapharm India in Verna, Goa. The acquisition was first announced in October 2022. With the completion of the acquisition, Marksans will start operating at the acquired facility, , marksans pharma, acquisition, Tevapharm India, healthcare